Ms. Orr joined AnelleO as a consulting business lead and Board Member in June 2018. Ms. Orr has 20 of experience in drug development, starting as as a consultant and case team leader at Monitor Group leading launch strategies for pharmaceuticals and vaccines.
Ms. Orr spent 12 years at Liquidia Technologies, Inc., another UNC startup.A in a variety of Business Development, R&D, and Strategy roles including Vice President of Product Strategy.. 2018, Ms. Orr joined Camargo Pharmaceutical Services, a leading drug development outsourcing consulting firm, with a specific focus in 505(b)(2) drug development and regulatory strategy. Ms. Orr will help develop and advance AnelleO-PRO and the 3D printed IVR technology by taking full advantage of the potential AnelleO has with its platform technology.